Arch Therapeutics Receives Recommendation That CE Mark Be Granted [Seeking Alpha]
Arch Therapeutics, Inc. (ARTH)
NASDAQ:AMEX Investor Relations:
ir.archtherapeutics.com
Company Research
Source: Seeking Alpha
Arch Therapeutics Receives Recommendation That CE Mark Be Granted Summary Arch Therapeutics' AC5 recommended for European approval. There was no press release on the recommendation. AC5 will get the CE mark early next year. The company is in distribution discussions with potential partners. On November 19, 2019, Arch Therapeutics ( OTCQB:ARTH 10-K report MDD Although there is no guarantee, the decision making panel almost always follows the recommendation of the Notified Body. But this approval will come more than a year after it was originally expected. When Arch filed for the CE mark on November 28, 2018, they expected their Notified Body Arch properly did not put out a press release about receiving the recommendation. That will come only with the actual approval early next year. But they have been talking with potential distribution partners urisdictions that require During the last few years, Arch has done a series of small capital raises to keep the lights on until they got FDA a
Show less
Read more
Impact Snapshot
Event Time:
ARTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARTH alerts
High impacting Arch Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ARTH
Sec Filings
- 11/13/24 - Form SC
- 11/7/24 - Form 8-K
- 11/4/24 - Form 8-K
- ARTH's page on the SEC website